Schonfeld Strategic Advisors LLC Precigen, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.41 - $2.79 $86,997 - $172,143
-61,700 Reduced 45.54%
73,800 $156,000
Q2 2022

Aug 15, 2022
SELL
$1.15 - $2.53 $49,909 - $109,801
-43,400 Reduced 24.26%
135,500 $182,000
Q1 2022

May 16, 2022
BUY
$1.91 - $3.98 $341,699 - $712,022
178,900 New
178,900 $377,000

Others Institutions Holding PGEN

# of Institutions
140
Shares Held
161M
Call Options Held
232K
Put Options Held
69K
View Full List

About PRECIGEN, INC.

PGEN Quotes by TradingView
  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $281M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email